Inositol hexaphosphate: A potential chelating agent for uranium

Radiation Protection Dosimetry

Volumn 127, Issue 1-4, 2007, Pages 477-479

  Cebrian, D ^a   Tapia, A ^a   Real, A ^a   Morcillo, Mangel A ^a  

^a CIEMAT   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BICARBONATE; CITRIC ACID; ETIDRONIC ACID; PENTETIC ACID; PHYTIC ACID; URANIUM; CHELATING AGENT; RADIOPROTECTIVE AGENT;

ARTICLE; BINDING COMPETITION; CHELATION THERAPY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFICACY; IN VITRO STUDY; METAL BINDING; ANIMAL; DOSE RESPONSE; DRUG EFFECT; FEASIBILITY STUDY; HUMAN; ISOLATION AND PURIFICATION; METABOLIC CLEARANCE RATE; METABOLISM; RADIATION INJURY; RAT; TREATMENT OUTCOME;

ANIMALS; CHELATING AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEASIBILITY STUDIES; HUMANS; METABOLIC CLEARANCE RATE; PHYTIC ACID; RADIATION INJURIES; RADIATION-PROTECTIVE AGENTS; RATS; TREATMENT OUTCOME; URANIUM;

EID: 49649094550     PISSN: 01448420     EISSN: None     Source Type: Journal    
DOI: 10.1093/rpd/ncm356     Document Type: Article

References (14)

1. Brugee, D., de Lemos, J. L. and Oldmixon, B. Exposure pathways and health effects associated with chemical and radiological toxicity of natural uranium: A review. Review Environ. Health 30(3), 177-193 (2005).
2. World Health Organization (WHO). Uranium in drinking-water. WHO/SDE/WSH/ 03.04/118 (2005).
3. International Commission on Radiological Protection (ICRP). Age-dependent doses to members of the public from intake of radionuclides: Part 3 ingestion dose coefficients. ICRP Publication 69, Part 3 (Oxford: Pergamon Press) (1994).
4. Fukuda, S. Chelating agents used for plutonium and uranium removal in radiation emergency medicine. Current Med. Chem. 12, 2765-2770 (2005).
5. International Commission on Radiological Protection (ICRP). Protecting people against radiation exposure in the event of a radiological attack. ICRP Publication 96 (Oxford: Pergamon Press) (2006).
6. Pasquier, M. and Bourguignon, M. C. Thérapeutique des contaminations par l'uranium. C.R.S.S.A. 76 Travaux Scientifiques, no. 6, 149-154 (1977).
7. Hengé-Napoli, M. H., Archimbaud, M., Ansoborlo, E., Metivier, H. and Gourmelon, P. Efficacy of 3,4,3-LIHOPO for reducing the retention of uranium in rat after acute administration. Int. J. Radiat. Biol. 68(4), 389-393 (1995).
8. Szkudelski, T. Phytic acid-induced metabolic changes in the rat. J. Anim. Phys. Anim. Nutr. 89, 397-402 (2005).
9. Reddy, N. R. Foods Phytate (Boca Raton: CRC Press) (2001) ISBN 1566768675.
10. Braun, O., Contino, C., Hengé-Napoli, M.-H., Ansoborlo, E. and Pucci, B. Development of an in vitro test for screening of chelators of uranium. Analusis 27, 65-68 (1999).
11. Martinez, A. B., Cabrini, R. L. and Ubios, A. M. Orally administered ethane-1-hydroxy-1,1-bisphosphonate reduces the lethal effect of oral uranium poisoning. Health Phys. 78(6), 668-671 (2000).
12. Martínez, A. B., Mandalunis, P. M., Bozal, C. B., Cabrini, R. L. and Ubios, A. M. Renal function in mice poisoned with oral uranium and treated with ethane-1-hydroxy-1,1-bisphosphonate (EHBP). Health Phys. 85(3), 343-347 (2003).
13. Fukuda, S., Iida, H., Ikeda, M., Yan, X. and Xie, Y. Toxicity of uranium and the removal effects of CBMIDA and EHBP in simulated wounds of rats. Health Phys. 89(1), 81-88 (2005).
14. Henge-Napoli, M. H., Ansoborlo, E., Chazel, V., Houpert, P., Paquet, F. and Gourmelon, P. Efficacy of ethane-1-hydroxy-1,1-bisphosphonate (EHBP) for the decorporation of uranium after intramuscular contamination in rats. Int. J. Radiat. Biol. 75(11), 1473-1477 (1999).